Product Description
Since last many years Saintroy Lifescience is leading manufacture, export and supplierofCisplatin Injectionfrom Surat, Gujarat, India. Cisplatin Injection used to treat a number of cancers.
Tags: Cisplatin Injection manufacturer, Cisplatin Injection exporter,Cisplatin Injection supplier, and Cisplatin Injection, whogmp approved Cisplatin Injection manufacturer and supplier, Cisplatin Injection distributor, Cisplatin Injectionshipper, Cisplatin Injection 50 ml Cisplatin Injection 50 ml supplier,Cisplatin Injection 50 ml.
ISO/GMP/cGMP/WHOGMP/NAFDAC approved, PPB Kenya approved/USFDA approved/EUGMP approved/MOH Iran approved manufacturing facility inGujarat, India.
Registration: Saintroy Lifescience is interested in registrationof own brand or customer brands in ministry of health of clientscountry and we also provide the products samples, COA, COPP, ACTorCTD dossier, DMF, Manufacturing license, Free sales certificate and other required documents.
Export Country :Saintroy Lifescience Cisplatin Injection export toUSA, Canada, Germany, Europe, France, Ghana, Nigeria, Kenya, Senegal,Sudan,UAE, Kuwait, Dubai, Cameroon, Lebanon, Peru, Chile, Somalia, Philippines,Myanmar, Maldives, Thailand, Singapore, Malaysia, Hong Kong, China, Zimbabwe,Togo, Burkina Faso, Niger,Guinea Bissau, Congo, Democratic of republic, IvoryCosta, Oman, Guatemala, Nicaragua, Salvador, Qatar, Costa Rica, Panama, Cuba,Colombia, Bolivia, Argentine, Algeria, Guyana, Morocco, Jordan, Bahrain, Iran,Egypt, Kyrgyzstan, Uzbekistan, Kazakhstan.
Comprehensive Cancer TherapyCisplatin Injection is indicated for a range of cancers, including testicular, ovarian, bladder, and lung cancer. Its efficacy has made it a mainstay in chemotherapy protocols, often as part of combination therapy regimens. Administered intravenously, this medication targets malignant cells while requiring careful monitoring by experienced medical professionals.
Quality Manufacturing and SafetyProduced in GMP certified facilities, Cisplatin Injection assures high quality and stringent safety measures. The product is preservative-free to minimize risks of adverse reactions and is supplied in vials or ampoules for accurate dosage. Each batch undergoes strict quality checks before reaching hospitals, clinics, distributors, and exporters.
FAQ's of Cisplatin Injection:
Q: How is Cisplatin Injection administered?
A: Cisplatin Injection is administered intravenously by a healthcare professional, typically in a clinical or hospital setting. Dosage and infusion rate are determined by the physician based on the treatment protocol and the patient's health status.
Q: What precautions should be taken during Cisplatin treatment?
A: Treatment with Cisplatin requires strict medical supervision. Renal function and electrolyte levels must be closely monitored throughout therapy. As the drug is cytotoxic, healthcare professionals must handle it with appropriate protective measures.
Q: When is Cisplatin Injection indicated for use?
A: Cisplatin is prescribed for patients diagnosed with various cancers such as testicular, ovarian, bladder, and lung cancers. The timing and frequency of doses depend on the type of cancer and individual patient requirements.
Q: Where should Cisplatin Injection be stored?
A: The injection should be kept in a cool, dry place as directed by the manufacturer. It is essential to store it away from direct light and at recommended temperatures to ensure its efficacy and stability.
Q: What process should be followed before administering Cisplatin Injection?
A: Before administration, Cisplatin Injection must be prepared according to medical guidelines, ensuring compatibility with infusion fluids like saline or dextrose. Healthcare providers must wear protective gear due to its cytotoxic nature.
Q: What are the benefits of Cisplatin Injection in cancer treatment?
A: Cisplatin has proven effectiveness against several difficult-to-treat cancers. When used as part of a treatment protocol, it can improve survival rates and remission chances for many patients, especially in combination therapies.